1. Home
  2. DYAI vs OPAD Comparison

DYAI vs OPAD Comparison

Compare DYAI & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • OPAD
  • Stock Information
  • Founded
  • DYAI 1979
  • OPAD 2015
  • Country
  • DYAI United States
  • OPAD United States
  • Employees
  • DYAI N/A
  • OPAD N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • OPAD Real Estate
  • Sector
  • DYAI Health Care
  • OPAD Finance
  • Exchange
  • DYAI Nasdaq
  • OPAD Nasdaq
  • Market Cap
  • DYAI 28.3M
  • OPAD 25.3M
  • IPO Year
  • DYAI 2004
  • OPAD N/A
  • Fundamental
  • Price
  • DYAI $0.97
  • OPAD $2.00
  • Analyst Decision
  • DYAI Strong Buy
  • OPAD Hold
  • Analyst Count
  • DYAI 1
  • OPAD 5
  • Target Price
  • DYAI $6.00
  • OPAD $2.38
  • AVG Volume (30 Days)
  • DYAI 62.1K
  • OPAD 615.9K
  • Earning Date
  • DYAI 08-12-2025
  • OPAD 08-04-2025
  • Dividend Yield
  • DYAI N/A
  • OPAD N/A
  • EPS Growth
  • DYAI N/A
  • OPAD N/A
  • EPS
  • DYAI N/A
  • OPAD N/A
  • Revenue
  • DYAI $3,554,344.00
  • OPAD $794,159,000.00
  • Revenue This Year
  • DYAI $22.56
  • OPAD N/A
  • Revenue Next Year
  • DYAI $30.95
  • OPAD $40.79
  • P/E Ratio
  • DYAI N/A
  • OPAD N/A
  • Revenue Growth
  • DYAI 57.59
  • OPAD N/A
  • 52 Week Low
  • DYAI $0.91
  • OPAD $0.91
  • 52 Week High
  • DYAI $2.20
  • OPAD $5.13
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 46.17
  • OPAD 67.07
  • Support Level
  • DYAI $0.91
  • OPAD $1.31
  • Resistance Level
  • DYAI $1.03
  • OPAD $3.94
  • Average True Range (ATR)
  • DYAI 0.05
  • OPAD 0.36
  • MACD
  • DYAI 0.01
  • OPAD 0.10
  • Stochastic Oscillator
  • DYAI 41.67
  • OPAD 34.04

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About OPAD Offerpad Solutions Inc.

Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.

Share on Social Networks: